Apply for the SEG Incubator

Adial Pharmaceuticals and Tedor Pharma Announce Collaboration to Manufacture AD04 Through Commercialization

Adial Reaffirms on Track to Commence Phase 3 Trial in Q3 2019 Charlottesville, VA – June 6, 2019 – Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development of medicines for addiction,...

TEDOR Pharma LicensesFLEXITABTMBreakable Extended ReleaseTabletTechnology

Patent protected FLEXITAB technology delivers flexible and precise dosing from a single extended release tablet CUMBERLAND, RI – May [31], 2019 – TEDOR Pharma Inc., a Contract Development and Manufacturing Organization with an 18-year operating history, is pleased to...

ProThera Biologics Awarded $2-Million Fast Track NIH Grant

ProThera Biologics Awarded $2-Million Fast Track NIH Grant Company is Developing an Important Biomarker to Assess Outcomes in Neonates with Sepsis or Necrotizing Enterocolitis (NEC) in Support of Its Therapeutic Development Programs Providence, R.I., June 19, 2019 –...

URI awarded $20 million to further expand biomedical research capacity in R.I.

URI awarded $20 million to further expand biomedical research capacity in R.I. More than $80 million awarded to URI since program began in 2001 KINGSTON, R.I.– June 10, 2019 – A University of Rhode Island-based initiative that has successfully expanded biomedical...